Obesity Treatment Market Set for Remarkable Growth, Expected to Surpass USD 32.51 Billion with growing at 10.1% CAGR by 2030 | Key Players- AbbVie Incorporation, Apollo Endosurgery Inc., Arena Pharmaceuticals

The obesity treatment market size is projected to be valued at USD 14.02 billion in 2021 and is expected to rise to USD 32.51 billion by 2030. The market is expected to register a CAGR of 10.1% during the forecast period from 2022 to 2030.

𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐩𝐫𝐨𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐭𝐡𝐞 𝐝𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐨𝐛𝐞𝐬𝐢𝐭𝐲 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

• Key drivers driving market growth over the forecast period include an increased prevalence of chronic disorders and an obese population.
• Expanding health and fitness trends, such as gym culture, developing cosmetic difficulties, particularly among millennials, an increased propensity for weight-loss surgery, and rising healthcare expenditures, all provide opportunities for market growth.
• The availability of weight-management programs is increasing, there is a growing demand for technologically sophisticated weight-loss equipment, and more government measures are being implemented to raise awareness about obesity and its negative health consequences.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐀 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐨 𝐆𝐚𝐢𝐧 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/obesity-treatment-market/request-for-sample

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐎𝐛𝐞𝐬𝐢𝐭𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭?

A medical condition known as obesity-sometimes referred to as a disease-occurs when there is an accumulation of extra body fat that may be harmful to one's health. Being overweight contributes significantly to impairment and is linked to a number of illnesses, including osteoarthritis, cardiovascular disorders, type 2 diabetes, obstructive sleep apnea, and several types of cancer. There are environmental, socioeconomic, and individual reasons for obesity. Diet, exercise, technology, urbanization, genetic predisposition, drugs, mental health issues, economic policies, endocrine disruptions, and chemical exposure are a few of the recognized factors.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:

In this extremely competitive industry, major rivals constantly innovate and differentiate their products in an effort to take the lead in the market. Some of the leading companies in the obesity treatment market:

• AbbVie Incorporation
• Apollo Endosurgery Inc.
• Arena Pharmaceuticals
• Incorporation
• Atkins Nutritionals Ltd.
• Brunswick Corporation
• H. Boehringer Sohn AG & Ko. KG
• EnteroMedics
• Incorporation
• Hoffmann-La Roche Ltd.
• Herbalife Ltd.
• Johnson & Johnson Services Inc.
• Medtronic PLC
• Novo Nordisk A/S
• NutriSystem
• Incorporation

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/1561/2

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

• Increasing Prevalence of Obesity: The rising incidence of obesity worldwide, driven by sedentary lifestyles and unhealthy eating habits, is a major driver for the market.
• Advancements in Treatment Options: Innovations in pharmacological treatments and minimally invasive surgical techniques are expanding the options available for obesity management.
• Rising Awareness and Health Initiatives: Increased awareness about the health risks associated with obesity and government-led health initiatives are encouraging individuals to seek treatment.
• Growing Adoption of Bariatric Surgeries: The increasing acceptance and success rates of bariatric surgeries, such as gastric bypass and sleeve gastrectomy, are boosting the market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/obesity-treatment-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐁𝐫𝐞𝐚𝐤𝐝𝐨𝐰𝐧:

The obesity treatment market is mainly segmented based on surgery type, drug type, end-use, and region. Based on the surgery type research, Roux-en-Y gastric bypass (RYGB) is projected to have the most rapid expansion. The Roux-en-Y gastric bypass (RYGB) approach remains one of the most effective ways to lose weight, with an average excess weight loss of approximately 70% after a year.

Furthermore, according to drug type, the appetite suppressants sector industry held the most market share in 2021. Appetite suppressants are supplements that suppress hunger, resulting in less food consumption and weight loss.

𝐎𝐛𝐞𝐬𝐢𝐭𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• Biliopancreatic Diversion with Duodenal Switch (BPD/DS) segment is anticipated to grow at the highest CAGR over the forecast period. In the upcoming years, this market's growth is expected to be supported by rising surgical procedures demand and the rising prevalence of overweight-related health concerns like hypertension, type 2 diabetes, and other medical disorders.

• Combination therapies segment accounted high of the global revenue share. The prevalence of obesity is rising globally, and effective combination medicines for weight management are now available, which is driving this market's expansion.

• Asia-Pacific is expected to grow significantly over the projected period. Raising public awareness of the harmful impacts of obesity, bettering healthcare facilities, and increasing medical tourism are significant drivers of growth in this region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Advanced Wound Care Management Market: https://www.polarismarketresearch.com/industry-analysis/global-advanced-wound-care-management-market

Autoimmune Disease Diagnostics Market: https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market

Sepsis Diagnostics Market: https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market

Head And Neck Cancer Market: https://www.polarismarketresearch.com/industry-analysis/global-head-and-neck-cancer-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.